Mark Cushman c. Special Study Section <strong>for</strong> the Review <strong>of</strong> AIDS Proposals, National Institutes <strong>of</strong> Health, Bethesda, Maryland, April 27, 1988. d. National Cooperative Drug Discovery Groups <strong>for</strong> the Treatment <strong>of</strong> AIDS Review Committee Meeting, National Institutes <strong>of</strong> Health, Bethesda, Maryland, June 27-30, 1988. e. Special NCDDG Review Committee, National Institutes <strong>of</strong> Health, Washington, D. C., November 20-21, 1988. f. The National Institute <strong>of</strong> Allergy and Infectious Diseases Ad Hoc Review <strong>of</strong> Competing Contract Proposals, Bethesda, Maryland, June 27-28, 1989. g. Source Selection Meeting <strong>for</strong> RFP Nos. NIH-NIAID-89-14 (Analytical Chemistry <strong>of</strong> Chemicals and Pharmaceutical Products <strong>for</strong> Treatment <strong>of</strong> Infectious Diseases) and NIH- NIAID-AIDSP-89-13 (Resynthesis <strong>of</strong> Potential Therapeutic Agents <strong>for</strong> Treatment <strong>of</strong> Infectious Diseases), Bethesda, Maryland, September 28, 1989. h. Review <strong>of</strong> NIH grant application 1 R13 CA55099 to fund a conference on "Antisense Strategies", March 27, 1991. i. Member, NIH Medicinal Chemistry Study Section AHR-B1, April 7, 1994. k. Member, Editorial Advisory Board, The Journal <strong>of</strong> Organic Chemistry, 1999-2004. l. Member, Editorial Advisory Board, The Journal <strong>of</strong> Medicinal Chemistry, 2005-2010. m. Member, NIH SBCA Study Section, June 22, 2005. n. Presided at session entitled "New Strategies <strong>for</strong> Modern Medicinal Chemistry II", Regional American Chemical Society Meeting, Milwaukee, Wisconsin, May 31, 2006. o. Member, NIH SBCA Study Section, June 7, 2010. p. Member, ACS Medicinal Chemistry Predoctoral Fellowship Selection Committee, 2011. r. Reviewer <strong>for</strong> American Cancer Society junior investigator award, 2012. s. Associate Editor, Journal <strong>of</strong> Medicinal Chemistry, 2012. Undergraduate Students Mentored Since 2002: Marintha Rae Meckley, 2002 Samba Jarju, 2003 Michael Sauvel, 2003 Lauren Carlson, 2004 Brian Fort, 2004 Jamin Stefan, 2005 Seth Parmley, 2005 Michael Placzek, 2005 Meghan Breen, 2006 Nicholas Empey, 2007 Sean Deguire, 2007 Brenda E. Cordero Sanchez, 2007 Alexandria Reed, 2008 Erin Brown, 2009 Qingnuo Lin, 2011 Brooklyn Cobb, 2011 Rubayat Khan, 2012 Dennis Monteleone, 2012 Stephanie Pitman, 2013 Past and Present Graduate Students: Frederick W. Dekow 1975-l977 M.S. "Synthesis <strong>of</strong> Protoberberine Alkaloids" Support: NIH 48
Mark Cushman Harold S. Burlhis 1976-l978 M.S. "Studies Toward the Synthesis <strong>of</strong> Yohimbines" Support: NIH S. Peter Foltis 1979-l98l M.S. "Chemical and Biological Studies <strong>of</strong> Mal<strong>for</strong>min, a Metabolite <strong>of</strong> Aspergillus niger Support: NIH Diana Lee Darling 1977-l981 Ph.D. "Fluorinated Analogs <strong>of</strong> Rib<strong>of</strong>lavin: Potential Antimetabolites" Support: NIH Mary P. Koleck 1979-1983 Ph.D. "Total Synthesis <strong>of</strong> Chelidonine" Support: NIH Prem Mohan l981-1984 Ph.D. "Total Synthesis and Antitumor Evaluation <strong>of</strong> Analogs <strong>of</strong> Nitidine Chloride and Fagaronine Chloride" Support: NIH Wai Cheong Wong 198l-1984 Ph.D. "Total Synthesis <strong>of</strong> Corydalic Acid Methyl Ester" Support: NIH Jer-kang Chen 1983-1988 Ph.D. "Asymmetric Synthesis <strong>of</strong> Benzophenanthridine Alkaloids" Support: NIH and TA Donald Patrick 1984-1988 Ph.D. "Synthesis <strong>of</strong> Antisense Oligonucleotide-Intercalator Conjugates as Potential Anti-AIDS Agents" Support: NIH Eung-Seok Lee 1987-1992 Ph.D. "Design and Synthesis <strong>of</strong> Potential Protein-tyrosine Kinase Inhibitors" Support: NIH 49
- Page 1 and 2: CURRICULUM VITAE - MARK CUSHMAN Mar
- Page 3 and 4: 3 Mark Cushman 16. M. Cushman and D
- Page 5 and 6: Mark Cushman Pteridines and Folic A
- Page 7 and 8: Mark Cushman 87. K. Iwasa, M. Kamig
- Page 9 and 10: 9 Mark Cushman 123. M. Cushman, H.-
- Page 11 and 12: Mark Cushman 155. T. Sambaiah, P. E
- Page 13 and 14: 13 Mark Cushman 183. M. A. Silvestr
- Page 15 and 16: 15 Mark Cushman 212. M. Cushman, G.
- Page 17 and 18: Mark Cushman 239. A. Morrell, S. An
- Page 19 and 20: 19 Mark Cushman 265. R.-R. Kim, B.
- Page 21 and 22: Mark Cushman 291. A. Talukdar, Y. Z
- Page 23 and 24: Mark Cushman 18. "Synthesis and Ant
- Page 25 and 26: Mark Cushman 27. Mark S. Cushman an
- Page 27 and 28: Mark Cushman MZ, NA, NG, NI, NO, NZ
- Page 29 and 30: Mark Cushman Licensed Inventions: 1
- Page 31 and 32: Mark Cushman 35. "Inhibition of Rev
- Page 33 and 34: Mark Cushman 68. "A Hexacarboxylic
- Page 35 and 36: Mark Cushman Potential Aromatase In
- Page 37 and 38: 37 Mark Cushman Dexheimer, Yves Pom
- Page 39 and 40: 39 Mark Cushman 4. "Total Synthesis
- Page 41 and 42: 41 Mark Cushman 41. "Design, Synthe
- Page 43 and 44: Mark Cushman 75. "From the Hood to
- Page 45 and 46: Mark Cushman 41. $20,000, American
- Page 47: Mark Cushman s. Graduate Admissions
- Page 51 and 52: "Design and Synthesis of Protein-ty
- Page 53 and 54: Dr. Joseph Valko 1978-1979 "Total S
- Page 55 and 56: Dr. Hu-Ming He 1990-1996 "Design an
- Page 57 and 58: 2001-2004 "Ligands for Probing the